We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking 4502? Get live short interest, options flow, and signals on ORTEX.Sign up free →
45

Takeda Pharmaceutical Company Limited (4502) short interest & options flow

TSE

4502 heads into its October 29 earnings release with short sellers in full retreat, borrowing costs near a monthly low, and the stock up 4.3% on the week. The clearest shift in positioning is in the lending market. Cost to borrow has fallen sharply, dropping around 30% over the past month to 0.83% after spiking as high as 4.36% in late September. That spike looks transient…

Latest pulse30 Sept 2026

4502 cost to borrow surges to 3.50%, up 120% over one week amid tightening borrow supply.

6593.00-1.20% 1d-0.81% 1w+12.84% 1mClose: 10 Nov 2026
Cost to borrow
Low
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$66.70B
Next earnings
10 Dec 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 11 Nov 2026

ORTEX chart of Takeda Pharmaceutical Company Limited (4502) share price and short interest (% of free float), six months to November 10, 2026

4502 news and analysis

RSS

No long-form analysis yet for 4502. Pulse alerts and the live data picture are available on ORTEX.

Open 4502 on ORTEX →

Want the live picture for 4502?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for 4502 — free to start on ORTEX.

Sign up for free →Open 4502 on ORTEX